Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 700-107-9 | CAS number: 87189-25-1
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Skin sensitisation
Administrative data
- Endpoint:
- skin sensitisation: in vivo (LLNA)
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 17 September 2008 - 01 October 2008
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 008
- Report date:
- 2008
Materials and methods
Test guidelineopen allclose all
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 429 (Skin Sensitisation: Local Lymph Node Assay)
- Version / remarks:
- 2002
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- EU Method B.42 (Skin Sensitisation: Local Lymph Node Assay)
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- EPA OPPTS 870.2600 (Skin Sensitisation)
- Deviations:
- no
- GLP compliance:
- yes
- Type of study:
- mouse local lymph node assay (LLNA)
Test material
- Reference substance name:
- zinc(2+) 3-hydroxypropane-1,2-bis(olate)
- EC Number:
- 700-107-9
- Cas Number:
- 87189-25-1
- Molecular formula:
- (C3H6O3Zn)n
- IUPAC Name:
- zinc(2+) 3-hydroxypropane-1,2-bis(olate)
- Details on test material:
- - Substance type: Organic
- Physical state: Powder
- Storage condition of test material: At room temperature in the dark
Constituent 1
In vivo test system
Test animals
- Species:
- mouse
- Strain:
- CBA
- Sex:
- female
- Details on test animals and environmental conditions:
- TEST ANIMALS
- Source: Charles River France, L'Arbresle Cedex France
- Age at study initiation: approximately 11 weeks
- Weight at study initiation: preliminary test: 20 g, main study: 22-25 g (not exceed 20% of the mean weight)
- Housing: individual housing in labeled Macrolon cages (MI type; height 12.5 cm) containing sterilized sawdust as bedding material (Litalabo, S.P.P.S., Argenteuil, France). Paper (Enviro-dri, Wm. Lillico & Son (Wonham Mill Ltd), Surrey, United Kingdom) was supplied as cage-enrichment. The paper was removed on Day 1 prior to dosing and was supplied again after scoring of the ears on Day 3.
- Diet ad libitum: pelleted rodent diet (SM R/M-Z from SSNIFF Spezialdiäten GmbH, Soest, Germany)
- Water ad libitum: tap water
- Acclimation period: at least 5 days before the start of the experiment
- other information: all females were nulliparous and non-pregnant
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 20.5-23.6°C
- Humidity (%): 43-85%
- Air changes (per hr): 15 air changes per hour
- Photoperiod (hrs dark / hrs light): 12h artificial fluorescent light / 12h darkness per day
Study design: in vivo (LLNA)
- Vehicle:
- propylene glycol
- Remarks:
- Merck, Darmstadt, Germany
- Concentration:
- 0% (negative control with propylene glycol), 10% , 25%, 50%
- No. of animals per dose:
- 5 animals per concentration
- Details on study design:
- TEST ARTICLE PREPARATION:
The test substance formulations (w/w) for topical application on the ears were prepared within 4 hours prior to each treatment. No adjustment was made for specific gravity of the vehicle. Homogeneity was obtained to visually acceptable levels. The formulations showed as white suspensions. Homogeneity with the vehicle was accomplished to a visually acceptable level. Prior to dosing the preparations were mixed thoroughly.
RANGE FINDING TESTS
Concentrations: 25% and 50%
Animals: 2 (one for each concentration)
Age: 8-14 weeks
Body weight: 20 g
Each animal was treated with 1 concentration on 3 consecutive days. The dorsal surface of both ears was epidermally treated (25 microliters/ear) with the test article, at approximately the same time per day. 3-4 hours after the last exposure, the irritation of the ears was assessed. Ears of the animal at 50% were cleaned of residual test substance with tap water. Body weights were determined on day 3 (19 and 20 g). The animals were sacrificed after the final observation and no necropsy was performed. No skin reaction occurred during this preliminary irritation study.
TREATMENT AND ADMINISTRATION (MAIN STUDY)
INDUCTION EXPOSURE
- No. of exposures: 3 (1 per day)
- Exposure period: 3 consecutive days
- Test groups: 3 (10%, 25%, 50% of test article)
- Control group: 1 (propylene glycol only)
- Site: dorsal surface of both ears (25 µl/ear)
- Frequency of applications: 1/day
TREATMENT/MEASUREMENT
-Treatment: 3 days after the last exposure
- Injection: via the tail vein with 0.25 ml of sterile buffered saline (PBS) containing 20 µCi of 3H-methyl thymidine
- After 5 hours, animals were killed by intraperitoneal injection with pentobarbital Euthesate (0.2 ml/animal) and the draining (auricular) lymph node of each ear was excised. The relative size of the nodes (as compared to control) was estimated by visual examination and abnormalities of the nodes and surrounding area were recorded. The nodes were pooled for each animal in approximately 3 ml PBS.
- Tissue processing for radioactivity: A single cell suspension of lymph node cells (LNC) was prepared in PBS by gently separation through stainless steel gauze (diameter 125 µm). LNC were washed twice with an excess of PBS. To precipitate the DNA, the LNC were exposed to 5% trichloroacetic acid (TCA) at 4°C during the night.
- Radioactivity measurements: Precipitates were recovered by centrifugation, resuspended in TCA and transferred to Ultima Gold cocktail as the scintillation fluid. Radioactive measurements were performed using a scintillation counter. Counting time was to statistical precision of +/-0.2% or a maximum of 5 minutes whichever comes first. The scintillation counter was programmed to automatically subtract background and convert Counts per Minute (CPM) to Disintegrations per Minute (DPM).
CRITERIA USED TO CONSIDER A POSITIVE RESPONSE:
If the results indicate a SI (Simulation Index, which is the ratio of the DPM/group compared to DPM/vehicle control group) is equal or higher than 3, the test substance may be regarded as skin sensitizer, based on the test guideline and recommendations done by ICCVAM. - Positive control substance(s):
- hexyl cinnamic aldehyde (CAS No 101-86-0)
Results and discussion
- Positive control results:
- Concentrations of 0, 5, 10 and 25% of alpha-hexylcinnamicaldehyde in acetone:olive oil (4:1) were tested under conditions comparable to the study design. The SI values calculated for the positive control in concentrations of 0, 5, 10 and 25% were 1.0, 1.7, 2.8 and 3.6 respectively. An EC3 (estimated concentration that will give a SI = 3) value of 13.8% was calculated using linear interpolation. The calculated EC3 value was found to be in the acceptable range of 2 and 20%. Based on these results, it can be concluded that the LLNA as performed is an appropriate model.
In vivo (LLNA)
Resultsopen allclose all
- Parameter:
- SI
- Remarks on result:
- other: The SI values calculated for the substance concentrations 10, 25 and 50% were 1.4, 1.2 and 1.2 respectively. For further information see table 1.
- Parameter:
- other: disintegrations per minute (DPM)
- Remarks on result:
- other: Mean DPM/animal values for the experimental groups treated with test substance concentrations 10, 25 and 50% were 643, 555 and 533 respectively. The mean DPM/animal value for the vehicle contol group was 460. For further information see table 1.
Any other information on results incl. tables
No irritation of the ears was observed in any of the animals examined. Test substance remnants at 50% prevented scoring for erythema, no oedema was observed in this dose group (see table 2). All nodes of the experimental and control groups were considered normal in size. No macroscopic abnormalities of the surrounding area were noted.
No changes in body weights were observed (see table 3). Individual radioactivity measures are given in table 4.
Table 1: Disintegrations Per Minute (DPM) and Stimulation Index
Group |
% Test Substance |
mean DPM +/- SEM |
SI +/- SEM |
1 |
0% |
460 +/- 60 |
1.0 +/- 0.2 |
2 |
10% |
643 +/- 104 |
1.4 +/- 0.3 |
3 |
25% |
555 +/- 122 |
1.2 +/- 0.3 |
4 |
50% |
533 +/- 61 |
1.2 +/- 0.2 |
Table 2: Skin reactions and relative size auricular lymph nodes
Concentration |
Animal No. |
Skin reactions (day 3) |
Lymph node size (day 6) |
||||
|
|
Left ear |
Right ear |
Left ear |
Right ear |
||
erythema |
edema |
erythema |
edema |
|
|
||
0 |
1 |
0 |
0 |
0 |
0 |
n |
n |
2 |
0 |
0 |
0 |
0 |
n |
n |
|
3 |
0 |
0 |
0 |
0 |
n |
n |
|
4 |
0 |
0 |
0 |
0 |
n |
n |
|
5 |
0 |
0 |
0 |
0 |
n |
n |
|
10 |
6 |
0 |
0 |
0 |
0 |
n |
n |
7 |
0 |
0 |
0 |
0 |
n |
n |
|
8 |
0 |
0 |
0 |
0 |
n |
n |
|
9 |
0 |
0 |
0 |
0 |
n |
n |
|
10 |
0 |
0 |
0 |
0 |
n |
n |
|
25 |
11 |
0 |
0 |
0 |
0 |
n |
n |
12 |
0 |
0 |
0 |
0 |
n |
n |
|
13 |
0 |
0 |
0 |
0 |
n |
n |
|
14 |
0 |
0 |
0 |
0 |
n |
n |
|
15 |
0 |
0 |
0 |
0 |
n |
n |
|
50 |
16 |
G |
0 |
G |
0 |
n |
n |
17 |
G |
0 |
G |
0 |
n |
n |
|
18 |
G |
0 |
G |
0 |
n |
n |
|
19 |
G |
0 |
G |
0 |
n |
n |
|
20 |
G |
0 |
G |
0 |
n |
n |
|
n: considered to be normal, G: Scoring for erythema was not possible due to white test substance remnants. |
Table 3: Mean body weights in grams
|
Concentration (%) |
|||
0 |
10 |
25 |
50 |
|
Day 1 |
23.6 |
23.4 |
24.6 |
24 |
Day 6 |
23 |
22.6 |
23.2 |
23.2 |
Table 4: Radioactivity measurements (individual animals)
group |
% test substance |
animal |
DPM / animal |
|
1 |
0% |
1 |
310 |
|
(Vehicle) |
2 |
388 |
||
3 |
644 |
|||
4 |
545 |
|||
5 |
413 |
|||
2 |
10% |
6 |
576 |
|
7 |
976 |
|||
8 |
774 |
|||
9 |
385 |
|||
10 |
505 |
|||
3 |
25% |
11 |
297 |
|
12 |
269 |
|||
13 |
613 |
|||
14 |
916 |
|||
15 |
678 |
|||
4 |
50% |
16 |
578 |
|
17 |
427 |
|||
18 |
402 |
|||
19 |
741 |
|||
20 |
517 |
Applicant's summary and conclusion
- Interpretation of results:
- GHS criteria not met
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.